Molecular Endocrinology, Vol 7, 462-467, Copyright © 1993 by Endocrine Society

ARTICLES

The human osteocalcin promoter directs bone-specific vitamin D- regulatable gene expression in transgenic mice

RA Kesterson, L Stanley, F DeMayo, M Finegold and JW Pike
Department of Cell Biology, Baylor College of Medicine, Houston, Texas 77030.

Osteocalcin is a major noncollagenous protein of bone regulated by 1,25- dihydroxyvitamin D3 [1,25-(OH)2D3] and is believed to be expressed only by differentiated osteoblasts. We introduced a 3.9-kilobase human osteocalcin gene promoter (hOCP)-chloramphenicol acetyltransferase (CAT) fusion gene into the germ line of mice. Examination of tissue extracts from these transgenic mice demonstrated that the expression of CAT was restricted to bone-associated tissues and the brain. Immunohistochemical staining of femur tissue sections using CAT antibodies localized the production of CAT protein to osteoblasts and maturing chondrocytes. Previous studies via transient transfection into osteoblast-like cells have identified a vitamin D response element approximately 500 basepairs up-stream of the hOCP capable of mediating 1,25-(OH)2D3 induction. As a consequence, regulation of the transgene was examined in homozygous transgenic lines for sensitivity to 1,25- (OH)2D3. Hormonal deficiency was created using a low calcium diet supplemented with 0.8% SrCl2 for 7 days and was restored in experimental mice by injection of 25 ng 1,25-(OH)2D3/day, ip, for 3 days. The low vitamin D3 diet decreased CAT activity several-fold in extracts from calvaria, femur, and brain compared to that in mice maintained on a normal diet, while 1,25-(OH)2D3 supplementation restored and enhanced CAT activity over control values. These data demonstrate that hOCP is sufficient to direct osteoblast-specific 1,25- (OH)2D3-sensitive gene expression in mice in addition to the unexpected regulatable expression in brain tissue.

This article has been cited by other articles:

				D. Jiang, R. T. Franceschi, H. Boules, and G. Xiao Parathyroid Hormone Induction of the Osteocalcin Gene: REQUIREMENT FOR AN OSTEOBLAST-SPECIFIC ELEMENT 1 SEQUENCE IN THE PROMOTER AND INVOLVEMENT OF MULTIPLE SIGNALING PATHWAYS J. Biol. Chem., February 13, 2004; 279(7): 5329 - 5337. [Abstract] [Full Text] [PDF]

				C.-L. Hsieh, L. Yang, L. Miao, F. Yeung, C. Kao, H. Yang, H. E. Zhau, and L. W. K. Chung A Novel Targeting Modality to Enhance Adenoviral Replication by Vitamin D3 in Androgen-independent Human Prostate Cancer Cells and Tumors Cancer Res., June 1, 2002; 62(11): 3084 - 3092. [Abstract] [Full Text] [PDF]

				G. Zhao, M.-C. Monier-Faugere, M. C. Langub, Z. Geng, T. Nakayama, J. W. Pike, S. D. Chernausek, C. J. Rosen, L.-R. Donahue, H. H. Malluche, et al. Targeted Overexpression of Insulin-Like Growth Factor I to Osteoblasts of Transgenic Mice: Increased Trabecular Bone Volume without Increased Osteoblast Proliferation Endocrinology, July 1, 2000; 141(7): 2674 - 2682. [Abstract] [Full Text] [PDF]

				A. M. Craciun, C. Vermeer, H.-G. Eisenwiener, N. Drees, and M. H.J. Knapen Evaluation of a Bead-based Enzyme Immunoassay for the Rapid Detection of Osteocalcin in Human Serum Clin. Chem., February 1, 2000; 46(2): 252 - 257. [Abstract] [Full Text] [PDF]

				Z. Hou, Q. Nguyen, B. Frenkel, S. K. Nilsson, M. Milne, A. J. van Wijnen, J. L. Stein, P. Quesenberry, J. B. Lian, and G. S. Stein Osteoblast-specific gene expression after transplantation of marrow cells: Implications for skeletal gene therapy PNAS, June 22, 1999; 96(13): 7294 - 7299. [Abstract] [Full Text] [PDF]

				R.T. Franceschi The Developmental Control of Osteoblast-Specific Gene Expression: Role of Specific Transcription Factors and the Extracellular Matrix Environment Critical Reviews in Oral Biology & Medicine, January 1, 1999; 10(1): 40 - 57. [Abstract] [Full Text] [PDF]

				J.-L. Frendo, G. Xiao, S. Fuchs, R. T. Franceschi, G. Karsenty, and P. Ducy Functional Hierarchy between Two OSE2 Elements in the Control of Osteocalcin Gene Expression in Vivo J. Biol. Chem., November 13, 1998; 273(46): 30509 - 30516. [Abstract] [Full Text] [PDF]

				N. A. Sims, C. P. White, K. L. Sunn, G. P. Thomas, M. L. Drummond, N. A. Morrison, J. A. Eisman, and E. M. Gardiner Human and Murine Osteocalcin Gene Expression: Conserved Tissue Restricted Expression and Divergent Responses to 1,25-Dihydroxyvitamin D3 in Vivo Mol. Endocrinol., October 1, 1997; 11(11): 1695 - 1708. [Abstract] [Full Text]

				X.-P. Yu and S. Chandrasekhar Parathyroid Hormone (PTH 1-34) Regulation of Rat Osteocalcin Gene Transcription Endocrinology, August 1, 1997; 138(8): 3085 - 3092. [Abstract] [Full Text] [PDF]

				N. Nogues, J. A. Del RIo, M. Perez-Riba, E. Soriano, R. A. Flavell, and A. Boronat Placenta-Specific Expression of the Rat Growth Hormone-Releasing Hormone Gene Promoter in Transgenic Mice Endocrinology, August 1, 1997; 138(8): 3222 - 3227. [Abstract] [Full Text] [PDF]

				B. Frenkel, C. Capparelli, M. van Auken, D. B. , J. Bryan, J. L. Stein, G. S. Stein, and J. B. Lian Activity of the Osteocalcin Promoter in Skeletal Sites of Transgenic Mice and during Osteoblast Differentiation in Bone Marrow-Derived Stromal Cell Cultures: Effects of Age and Sex Endocrinology, May 1, 1997; 138(5): 2109 - 2116. [Abstract] [Full Text] [PDF]

				F. Yeung, W. K. Law, C.-H. Yeh, J. J. Westendorf, Y. Zhang, R. Wang, C. Kao, and L. W. K. Chung Regulation of Human Osteocalcin Promoter in Hormone-independent Human Prostate Cancer Cells J. Biol. Chem., January 18, 2002; 277(4): 2468 - 2476. [Abstract] [Full Text] [PDF]